Predictors of Pap smear testing uptake among women in Lagos, Nigeria.

Content Provider	Europe PMC
Author	Okunade, Kehinde S John-Olabode, Sarah Adejimi, Adebola A Oshodi, Yusuf A Osunwusi, Benedetto Ugwu, Aloy O Adefemi, Ayodeji Anorlu, Rose I
Copyright Year	2022
Abstract	We assessed the predictors of Pap smear testing uptake within 6 months after cervical cancer prevention education among women in Lagos, Nigeria. This was a prospective follow-up study conducted as part of the ‘mHealth-Cervix trial’ in the two teaching hospitals in Lagos, Nigeria, between August 2020 and April 2021. Participants were followed up for 6 months after pre-enrolment cervical cancer prevention education. The potential socio-demographic and clinical predictors of Pap smear testing uptake during the 6-month follow-up were tested using the predictive model in a binary logistic regression analysis. Statistical significance was reported as p < 0.05. The rate of Pap smear testing uptake during the 6-month follow-up was 35.7%. Following the adjustments in the final multivariate analysis, participants’ previous awareness of Pap smearing (RR = 6.92, 95% CI: 8.37–56.68, p = 0.001) and attendance at the general outpatient clinic during the period of follow-up (RR = 11.22, 95% CI: 1.54–81.51, p = 0.017) independently predict Pap smear testing uptake. We will, therefore, explore the impact of continuous provision of health promotion on cervical cancer prevention and its effect in the context of routine clinical care in our next implementation research agenda. We recommend, in the meantime, that regular health education of women on cervical cancer prevention by healthcare providers should be further reinforced as an integral part of health promotion in clinics to reduce the burden of cervical cancer in most low- and middle-income settings.
Journal	ecancermedicalscience
Volume Number	16
PubMed Central reference number	PMC9085162
PubMed reference number	35685953
e-ISSN	17546605
DOI	10.3332/ecancer.2022.1368
Language	English
Publisher	Cancer Intelligence
Publisher Date	2022-03-31
Access Restriction	Open
Rights License	This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. © the authors; licensee ecancermedicalscience.
Subject Keyword	cervical cancer health promotion mHealth-Cervix Nigeria Pap smear uptake
Content Type	Text
Resource Type	Article
Subject	Oncology Cancer Research